AddLife bought Edge Medical, COSCIENS bought Nualtis. one of these tells you much more than the other
wo small healthcare deals, one real difference. AddLife AB bought Edge Medical Ltd, a UK and Ireland distributor of specialist orthopaedic surgery products, for SEK 260M, approx. 2.6x revenue. the release gives c.SEK 100M revenue and an EBITDA margin above 30%, and says it was signed and completed the same day. COSCIENS Biopharma bought Nualtis Corp, a pharmaceutical drug delivery and CDMO business, for US$15M. that's all I found. no revenue, no profit, nothing on structure. i can't say which price is better, one comes with context and the other is just a number. but as a sell side person, which would you rather have your name on, and does a seller who discloses more usually get a better outcome or just a more scrutinized one? genuinely asking.
